HomeNewsBusinesscommoditiesOil steady as US stockpiles fall but Iran talks weigh

Oil steady as US stockpiles fall but Iran talks weigh

Brent crude futures slipped 2 cents to $91.53 a barrel at 1430 GMT, while U.S. West Texas Intermediate crude was at $89.71 a barrel, up 5 cents, or 0.1%.

February 10, 2022 / 21:20 IST
Story continues below Advertisement
Representative image
Representative image

Oil prices held broadly steady on Thursday after rallying on an unexpected drop in U.S. crude inventories in the previous session, as investors awaited the outcome of U.S.-Iran nuclear talks that could add crude supplies quickly to global markets.

Brent crude futures slipped 2 cents to $91.53 a barrel at 1430 GMT, while U.S. West Texas Intermediate crude was at $89.71 a barrel, up 5 cents, or 0.1%.

Story continues below Advertisement

Robust demand recovery from the coronavirus pandemic has kept global oil supplies snug, with inventories at key fuel hubs globally hovering at multi-year lows.

ALSO READ: Can rising crude oil prices spoil the India revival story?

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show